| |
|
|
|
|
|
Analytes in the HbA1c Programme
|
Company:
Date:
December 14, 2008
|
|
|
|
|
|
|
|
|
|
1 mL Super
|
Company:
Date:
December 14, 2008
|
|
|
|
|
|
|
|
|
|
5 mL Super
|
Company:
Date:
December 14, 2008
|
|
|
|
|
|
|
|
|
|
1 mL High
|
Company:
Date:
December 14, 2008
|
|
|
|
|
|
|
|
|
|
5 mL High
|
Company:
Date:
December 14, 2008
|
|
|
|
|
|
|
|
|
|
1 mL Low
|
Company:
Date:
December 14, 2008
|
|
|
|
|
|
|
|
|
|
5 mL Low
|
Company:
Date:
December 14, 2008
|
|
|
|
|
|
|
|
|
|
4 Levels of 1 mL
|
Company:
Date:
December 14, 2008
|
|
|
|
|
|
|
|
|
|
Prepared from human plasma, this ASO depleted serum is intended for making interdilutions of ASO controls and calibrators. Total protein 4-7 g/dL, Biuret method. pH 7.2 ± 0.2; 0.2 mµ filtered.
|
Company:
Date:
December 14, 2008
|
|
|
|
|
|
|
|
|
|
Antistreptolysin O, commonly called ASO, is an antibody found in human blood produced upon an infection by Group A Streptococcus bacteria.
In an infected individual, the Group A Streptococci produced Streptolysin O acts as a protein antigen and causes the patient’s immune system to mount a defensive response with Antistreptolysin O antibodies. A rise in ASO titer level begins about 1 week after infection and peaks 2-3 weeks later. In the absence of complications or re-infection, the ASO titer will usually fall to pre-infection levels within 6-12 months. Approximately 80-85 of the patients who
|
Company:
Date:
December 14, 2008
|
|
|
|
|
|